Petrunkin, V. E. (1956). "Synthesis and properties of dimercapto derivatives of alkylsulfonic acids". Ukrainsky Khemichisky Zhurnal. 22: 603–607.
Aposhian, H.V.; Aposhian, M.M. (1990). "Meso-2,3-dimercaptosuccinic acid: Chemical, pharmacological and toxicological properties of an orally effective metal chelating agent". Annual Review of Pharmacology and Toxicology. 30 (1): 279–306. doi:10.1146/annurev.pa.30.040190.001431. PMID 2160791. /wiki/Doi_(identifier)
D. Gonzalez-Ramirez; M. Zuniga-Charles; A. Narro-Juarez; Y. Molina-Recio; K. M. Hurlbut; R. C. Dart; H. V. Aposhian (1 October 1998). "DMPS (2,3-Dimercaptopropane-1-sulfonate, Dimaval) Decreases the Body Burden of Mercury in Humans Exposed to Mercurous Chloride" (free full text). Journal of Pharmacology and Experimental Therapeutics. 287 (1): 8–12. PMID 9765315. http://jpet.aspetjournals.org/cgi/content/abstract/287/1/8
Rooney, James (2007). "The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury". Toxicology. 234 (3): 145–156. doi:10.1016/j.tox.2007.02.016. PMID 17408840. /wiki/Doi_(identifier)
Guzzi, GianPaolo; Caterina A.M. La Porta (2008). "Molecular mechanisms triggered by mercury". Toxicology. 244 (1): 1–12. doi:10.1016/j.tox.2007.11.002. PMID 18077077. /wiki/Doi_(identifier)
Van der Linde AA, Pillen S, Gerrits GP, Bouwes Bavinck JN (2008). "Stevens–Johnson syndrome in a child with chronic mercury exposure and 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy". Clin Toxicol. 46 (5): 479–81. doi:10.1080/15563650701779687. PMID 18568806. https://doi.org/10.1080%2F15563650701779687